Key result
Telemonitoring shows no benefit over standard management for quality of life in heart failure patients.
Why the study?
The study was conducted to evaluate the literature on telemonitoring in patients with heart failure to determine its impact on quality of life.
Does telemonitoring improve quality of life in patients with heart failure?
Meta-Analysis (n=579)
Does telemonitoring improve quality of life in patients with heart failure?
Effect estimate: Mean difference -0.75 (95% CI -7.08 to 5.58)
p-value: p=0.82
The use of telemedicine technologies does not significantly improve quality of life in patients with heart failure compared to standard management.
No QoL benefit from telemonitoring in HF; confirms standard care suffices and questions routine adoption.
Aim . To study the literature data and evaluate the telemonitoring results in patients with heart failure to determine their impact on the quality of life. Material and methods . We searched information according to PRISMA requirements using the following databases: PubMed, Embase, Crossref, MedLine, Clinical Trials and e-Library. Ten randomized controlled trials were selected for the final analysis of full-text articles. In these studies, the quality of life was analyzed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and EuroQol-5 Dimension (EQ-5D Utilities and EQ-5D VAS) questionnaire. Results. Among 285 patients with telemonitoring and 294 patients with standard management, MLHFQ did not reveal statistical significance (mean difference -0,75, -7,08-5,58, I2=97%, p=0,82). Similar results were obtained for the EuroQol-5 Dimension (EQ-5D VAS — mean difference 2,76, -1,23-6,74, I2=44%, p=0,18) and EQ-5D Utilities (mean difference 0,00, -0,05-0,05, I2=0%, p=1,00) questionnaires. Conclusion . The current systematic review and meta-analysis showed that the use of telemedicine technologies in patients with heart failure does not affect the quality of life of patients.
No takes yet. Share an insight, caveat, or question.
Гаранин et al. (2025) conducted a meta-analysis in Heart failure (n=579). Telemedicine technologies (telemonitoring) vs. Standard management was evaluated on Quality of life (Minnesota Living with Heart Failure Questionnaire) (Mean difference -0.75, 95% CI -7.08 to 5.58, p=0.82). Telemonitoring in heart failure patients did not significantly affect quality of life compared to standard management (MLHFQ mean difference -0.75; 95% CI -7.08 to 5.58; p=0.82).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: